Loading...

Loading...

Tirzepatide Prevents Major Cardiovascular Events: Eli Lilly
By MBN Staff - Mon, 08/18/2025 - 09:53
Eli Lilly reports that tirzepatide protects against adverse cardiovascular events, including cardiovascular death, myocardial infarction, or stroke.
https://mexicobusiness.news/tag/clinical-trial
More Health
FDA Approves Wegovy for Adults with MASH, Liver Fibrosis
By Sofía Garduño - Mon, 08/18/2025 - 09:14
The US FDA approves Wegovy to treat adults with MASH and moderate to advanced liver fibrosis, excluding cirrhosis.
J&J Files for FDA Approval of Oral Psoriasis Drug Icotrokinra
By Sofía Garduño - Tue, 07/22/2025 - 08:17
J&J submits NDA for icotrokinra, an oral IL-23 blocker for plaque psoriasis, based on four Phase 3 trials showing strong efficacy and safety.
Medtronic Expands Use of MiniMed 780G System in European Union
By MBN Staff - Tue, 07/22/2025 - 08:01
Medtronic expands MiniMed 780G use in the European Union to children, pregnant women, and people with type 2 diabetes, following CE Mark approval.
FDA Clears Rise Therapeutics' R-5780 for Cancer Trial
By MBN Staff - Tue, 01/14/2025 - 17:16
FDA clears Rise Therapeutics' R-5780 to begin a Phase 1 cancer trial, hoping to enhance immune checkpoint inhibitor effectiveness.

Pfizer’s Gene Therapy Surpasses Hemophilia A Treatments
By MBN Staff - Mon, 07/29/2024 - 09:54
Pfizer’s gene therapy significantly reduces bleeding episodes in hemophilia A, showing superior results over current treatments in a late-stage trial.
Visual Health, Bird Flu Concerns: The Week in Health
By Sofía Garduño - Thu, 07/04/2024 - 10:00
This week, COFEPRIS approved a clinical trial for a synthetic cornea, while experts are increasingly concerned about a potential bird flu pandemic.
AstraZeneca's Truqap Fails in Breast Cancer Trial
By MBN Staff - Wed, 06/19/2024 - 09:37
AstraZeneca's combination of Truqap and paclitaxel fails to meet primary objectives in a late-stage trial for triple-negative breast cancer.

Pfizer's DMD Gene Therapy Trial Fails
By MBN Staff - Thu, 06/13/2024 - 10:09
Pfizer's gene therapy for Duchenne muscular dystrophy (DMD) failed its late-stage trial, missing motion function goals.
Ozempic Reduces Kidney Decline in Type 2 Diabetes Patients
By Anmol Motwani - Wed, 05/29/2024 - 11:56
Semaglutide improves kidney function and reduces cardiovascular risks in Type 2 diabetes, a critical issue in global healthcare.